Prescription Drug Diversion
"Prescription Drug Diversion" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The transfer of prescription drugs from legal to illegal distribution and marketing networks.
Descriptor ID |
D064226
|
MeSH Number(s) |
I01.198.240.609 I01.880.735.191.204
|
Concept/Terms |
Prescription Drug Diversion- Prescription Drug Diversion
- Diversion, Prescription Drug
- Diversions, Prescription Drug
- Drug Diversion, Prescription
- Drug Diversions, Prescription
- Prescription Drug Diversions
- Controlled Substance Diversion
- Controlled Substance Diversions
- Diversion, Controlled Substance
- Diversions, Controlled Substance
- Substance Diversion, Controlled
- Substance Diversions, Controlled
|
Below are MeSH descriptors whose meaning is more general than "Prescription Drug Diversion".
Below are MeSH descriptors whose meaning is more specific than "Prescription Drug Diversion".
This graph shows the total number of publications written about "Prescription Drug Diversion" by people in this website by year, and whether "Prescription Drug Diversion" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2014 | 2 | 0 | 2 | 2015 | 2 | 1 | 3 | 2016 | 1 | 0 | 1 | 2018 | 2 | 0 | 2 | 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Prescription Drug Diversion" by people in Profiles.
-
Loskutova NY, Waterman J, Callen E, Staton EW, Bullard E, Shields J. Knowledge, Attitudes, and Practice Patterns of Health Professionals Toward Medical and Non-medical Stimulant Use by Young Adults. J Am Board Fam Med. 2020 Jan-Feb; 33(1):59-70.
-
Cumbler E, Kutner JS. Random Drug Testing of Physicians: A Complex Issue Framed in 7 Questions. J Hosp Med. 2019 01 08; 14(1):56-57.
-
Lebin JA, Murphy DL, Severtson SG, Bau GE, Dasgupta N, Dart RC. Scoring the best deal: Quantity discounts and street price variation of diverted oxycodone and oxymorphone. Pharmacoepidemiol Drug Saf. 2019 01; 28(1):25-30.
-
Wiegand TJ, Le Lait MC, Bartelson BB, Dart RC, Green JL. Analysis of the Abuse and Diversion of the Buprenorphine Transdermal Delivery System. J Pain. 2016 06; 17(6):745-52.
-
Bartels K, Binswanger IA, Hopfer CJ. Sources of Prescription Opioids for Nonmedical Use. J Addict Med. 2016 Mar-Apr; 10(2):134.
-
Dart RC, Surratt HL, Le Lait MC, Stivers Y, Bebarta VS, Freifeld CC, Brownstein JS, Burke JJ, Kurtz SP, Dasgupta N. Diversion and Illicit Sale of Extended Release Tapentadol in the United States. Pain Med. 2016 08; 17(8):1490-6.
-
Matlock DD. The Pain Pendulum Swinging Again. J Palliat Med. 2015 Sep; 18(9):734-5.
-
Binswanger IA, Glanz JM. Pharmaceutical Opioids in the Home and Youth: Implications for Adult Medical Practice. Subst Abus. 2015; 36(2):141-3.
-
Nussbaum AM, Thurstone C, McGarry L, Walker B, Sabel AL. Use and diversion of medical marijuana among adults admitted to inpatient psychiatry. Am J Drug Alcohol Abuse. 2015 Mar; 41(2):166-72.
-
Lavonas EJ, Severtson SG, Martinez EM, Bucher-Bartelson B, Le Lait MC, Green JL, Murrelle LE, Cicero TJ, Kurtz SP, Rosenblum A, Surratt HL, Dart RC. Abuse and diversion of buprenorphine sublingual tablets and film. J Subst Abuse Treat. 2014 Jul; 47(1):27-34.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|